As people age, clinicians often struggle to determine who will remain relatively healthy and who faces a higher risk of rapid decline. Now, new research suggests that critical clues may already circulate in the bloodstream.
A study led by researchers at Duke Health, in collaboration with the University of Minnesota, has found that small RNA molecules called piRNAs can accurately predict whether older adults are likely to survive at least two more years. The findings, published in Aging Cell, indicate that a simple blood test could eventually help identify short-term survival risks and guide strategies to promote healthy aging.
According to senior author Virginia Byers Kraus, a professor at the Duke University School of Medicine, a small combination of piRNAs proved to be the strongest predictor of two-year survival—outperforming age, lifestyle habits and other health measures examined in the study. She noted that the strength of the signal from a routine blood test was particularly striking.
Study Design and Advanced Data Analysis
To investigate the role of piRNAs, researchers analysed blood samples from adults aged 71 and older. They discovered that lower levels of certain piRNAs strongly correlated with longer survival. Previous research has shown that these small RNA molecules regulate processes such as development, regeneration and immune function.
As reported by medicalxpress, the team applied causal artificial intelligence and machine learning methods to evaluate 187 clinical variables and 828 different small RNAs across more than 1,200 blood samples. The samples came from a large North Carolina-based cohort established in an earlier Duke-led study. Researchers determined survival outcomes by linking participants to national mortality records.
Using advanced statistical modelling, the team identified a group of six piRNAs that alone predicted two-year survival with up to 86% accuracy. Importantly, they validated these results in a second independent group of older adults, strengthening confidence in the findings.
What Lower piRNA Levels May Indicate
Participants who lived longer consistently showed lower levels of specific piRNAs. Interestingly, this pattern mirrors findings in simple organisms, where reducing certain RNA molecules can extend lifespan.
Dr. Kraus explained that higher levels of particular piRNAs in blood may signal underlying biological stress or dysfunction. Therefore, understanding why these molecules increase could reveal new therapeutic targets aimed at promoting healthy aging.
When researchers compared piRNAs with traditional health indicators, they found that piRNAs outperformed age, cholesterol levels, physical activity and more than 180 other clinical measures in predicting short-term survival. However, for longer-term survival, lifestyle factors played a more prominent role, although piRNAs continued to provide meaningful biological insight.
Toward a Practical Clinical Tool
Looking ahead, the research team plans to examine whether interventions—such as medications, lifestyle modifications or emerging therapies like GLP-1–based drugs—can influence piRNA levels. They also intend to compare piRNA concentrations in blood with levels in tissues to better understand how these molecules function within the body.
Dr. Kraus described piRNAs as “micromanagers” that help regulate numerous processes affecting health and aging. She emphasised that scientists are only beginning to appreciate their biological impact.
Ultimately, the researchers aim to develop a practical, minimally invasive blood test capable of identifying short-term survival risk. By doing so, clinicians could intervene earlier and tailor strategies to improve health outcomes as people age.